We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
3-D imaging reveals unexpected arrangement of plaques in Alzheimer's-afflicted brains
News

3-D imaging reveals unexpected arrangement of plaques in Alzheimer's-afflicted brains

3-D imaging reveals unexpected arrangement of plaques in Alzheimer's-afflicted brains
News

3-D imaging reveals unexpected arrangement of plaques in Alzheimer's-afflicted brains

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "3-D imaging reveals unexpected arrangement of plaques in Alzheimer's-afflicted brains "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Rockefeller University researchers have used a recently-developed imaging technique that makes tissue transparent to visualize brain tissue from deceased patients with Alzheimer's disease, exposing nonrandom, higher-order structures of beta amyloid plaques—sticky clumps of a toxic protein typically found in the brains of people with Alzheimer's. The findings appear in the journal Cell Reports.


See Also: Study findings challenge a scientific principle about amyloid beta


"Until now, we've been studying the brain using 2D slices; and I've always felt that was inadequate, because it's a complex, 3D structure with many interlocking components," says senior author Marc Flajolet, an assistant professor in the Laboratory of Molecular and Cellular Neuroscience at The Rockefeller University. "Not only was slicing time consuming and 3D reconstruction laborious when not erroneous, it gave us a limited view. We needed some way to look at this 3D structure in all of its dimensions without preliminary slicing of the brain."


This image shows 3-D rendering of 3 different beta amyloid plaques. Credit: Dr. Thomas Liebmann, The Rockefeller University
 


The researchers wanted to go beyond the traditional 3D brain imaging (e.g., PET or fMRI scans), which show brain activity in a broad way, but have a low resolution overall. To circumvent this, the research team turned to a recently-developed method, called "iDISCO." Here, brains are soaked in a solution that imbue the fats within it with a charge, before being exposed to an electrical field with an opposite charge, which behaves like a magnet, forcing all of the fat out of the brain tissue.


The result, says Flajolet, is a brain that is hard and transparent, almost "like glass," which allowed the researchers to see the amyloid plaques in full detail and in 3D, in a full mouse brain hemisphere, as well as in small blocks of human brain tissue.


"In mouse models, plaques are rather small, homogenous in size and shape, and not grouped in any specific way," says Flajolet. "But in the human brain, we were seeing more heterogeneity, larger plaques and these new, complex patterns." These structures, called TAPs (three dimensional amyloid patterns) may have implications for the future of Alzheimer's disease treatment, he says. By comparing doctor's reports of a patient's symptoms with images of the patient's brain post-mortem, they may be able to classify different categories of Alzheimer's disease.


Learn More: Amyloid probes gain powers in search for Alzheimer's cause


"There are people with brains full of plaques and no dementia at all", he says, "and there are those with brains free of plaques with many of the symptoms." In light of that, the way that current clinical trials view the disease--namely, that there is one category--might be incorrect, he says. It's possible that current drugs may be beneficial only for a subset of Alzheimer patients, but we have no way to distinguish them at this day.


Flajolet stressed that, moving forward, we need a better understanding of these plaques, and Alzheimer's hallmarks in general, as the relationship between their presence and the severity of the disease is not clear-cut. "Perhaps this will lead to the development of new and better targeted drugs, or allow us to rethink the drugs we have now--that's what we hope for."


Note: Material may have been edited for length and content. For further information, please contact the cited source.


Cell Press


Publication

Leibmann Tet al. Three-Dimensional Study of Alzheimer’s Disease Hallmarks Using the iDISCO Clearing Method.   Cell Reports, Published Online July 14 2016. doi: 10.1016/j.celrep.2016.06.060


Advertisement